Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - LiveRamp Holdings, Inc.acxm-20160930ex32253fd0a.htm
EX-32.1 - EXHIBIT 32.1 - LiveRamp Holdings, Inc.acxm-20160930ex32151c008.htm
EX-31.2 - EXHIBIT 31.2 - LiveRamp Holdings, Inc.acxm-20160930ex3129f0260.htm
EX-31.1 - EXHIBIT 31.1 - LiveRamp Holdings, Inc.acxm-20160930ex311932deb.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2016

 

OR

 

[  ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ----- to -----

 

Commission file number 0-13163

 

Acxiom Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

DELAWARE

(State or Other Jurisdiction of
Incorporation or Organization)

71-0581897

(I.R.S. Employer

Identification No.)

 

 

P.O. Box 8190, 601 E. Third Street,

Little Rock, Arkansas

(Address of Principal Executive Offices)

72203-8190

(Zip Code)

 

 

(501) 342-1000

(Registrant's Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  [X]               No  [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes  [X]               No  [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [X]

Accelerated filer   [ ]

 

 

Non-accelerated filer [ ]

Smaller reporting company [ ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes  [ ]               No  [X]

 

The number of shares of common stock, $ 0.10 par value per share, outstanding as of November 4, 2016 was 77,468,461.

 


 

ACXIOM CORPORATION AND SUBSIDIARIES

INDEX

REPORT ON FORM 10-Q

September 30, 2016

 

Part I.  Financial Information 

Page No.

Item 1. 

Financial Statements

 

 

Condensed Consolidated Balance Sheets
as of September 30, 2016 (Unaudited) and March 31, 2016

3

 

Condensed Consolidated Statements of Operations
for the Three months ended September 30, 2016 and 2015 (Unaudited)

4

 

Condensed Consolidated Statements of Operations
for the Six months ended September 30, 2016 and 2015 (Unaudited)

5

 

Condensed Consolidated Statements of Comprehensive Income
for the Three months ended September 30, 2016 and 2015 (Unaudited)

6

 

Condensed Consolidated Statements of Comprehensive Income
for the Six months ended September 30, 2016 and 2015 (Unaudited)

7

 

Condensed Consolidated Statement of Equity
for the Six months ended September 30, 2016 (Unaudited)

8

 

Condensed Consolidated Statements of Cash Flows
for the Six months ended September 30, 2016 and 2015 (Unaudited)

9-10

 

Notes to Condensed Consolidated Financial Statements

11-25 

Item 2. 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26-39

Item 3. 

Quantitative and Qualitative Disclosures about Market Risk

40

Item 4. 

Controls and Procedures

40

 

 

 

Part II.  Other Information 

 

Item 1. 

Legal Proceedings

41

Item 1A. 

Risk Factors

41

Item 2. 

Unregistered Sales of Equity Securities and Use of Proceeds

41

Item 4. 

Mine Safety Disclosures

41

Item 5. 

Other Information

41

Item 6. 

Exhibits

42

 

 

 

Signature 

43

 

 

 

Exhibit Index 

44

 

 

2


 

 

PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

 

 

 

 

September 30, 

 

March 31, 

 

 

    

2016

    

2016

 

ASSETS

 

 

(Unaudited)

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

175,409

 

$

189,629

 

Trade accounts receivable, net

 

 

130,509

 

 

138,650

 

Refundable income taxes

 

 

5,347

 

 

9,834

 

Other current assets

 

 

42,916

 

 

37,897

 

Total current assets

 

 

354,181

 

 

376,010

 

 

 

 

 

 

 

 

 

Property and equipment, net of accumulated depreciation and amortization

 

 

174,936

 

 

183,043

 

Software, net of accumulated amortization

 

 

45,048

 

 

55,735

 

Goodwill

 

 

487,055

 

 

492,745

 

Purchased software licenses, net of accumulated amortization

 

 

8,792

 

 

10,116

 

Deferred income taxes

 

 

10,038

 

 

6,885

 

Other assets, net

 

 

22,007

 

 

25,315

 

 

 

$

1,102,057

 

$

1,149,849

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current installments of long-term debt

 

$

32,281

 

$

32,243

 

Trade accounts payable

 

 

36,300

 

 

37,717

 

Accrued expenses

 

 

 

 

 

 

 

Payroll

 

 

35,413

 

 

61,309

 

Other

 

 

46,581

 

 

48,254

 

Deferred revenue

 

 

33,394

 

 

44,477

 

Total current liabilities

 

 

183,969

 

 

224,000

 

 

 

 

 

 

 

 

 

Long-term debt

 

 

142,341

 

 

157,897

 

Deferred income taxes

 

 

53,532

 

 

53,964

 

Other liabilities

 

 

14,727

 

 

15,020

 

Commitments and contingencies

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

Common stock

 

 

13,190

 

 

13,039

 

Additional paid-in capital

 

 

1,115,194

 

 

1,082,220

 

Retained earnings

 

 

609,617

 

 

598,501

 

Accumulated other comprehensive income

 

 

7,616

 

 

8,590

 

Treasury stock, at cost

 

 

(1,038,129)

 

 

(1,003,382)

 

Total equity

 

 

707,488

 

 

698,968

 

 

 

$

1,102,057

 

$

1,149,849

 

 

See accompanying notes to condensed consolidated financial statements.

3


 

 

 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars in thousands, except per share amounts)

 

 

 

For the Three months ended

 

 

 

September 30, 

 

 

    

2016

    

2015

 

 

 

 

 

 

 

 

 

Revenues

 

$

217,267

 

$

207,345

 

Cost of revenue

 

 

120,105

 

 

121,312

 

Gross profit

 

 

97,162

 

 

86,033

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

 

19,029

 

 

19,078

 

Sales and marketing

 

 

37,847

 

 

34,259

 

General and administrative

 

 

32,866

 

 

31,519

 

Impairment of goodwill and other assets

 

 

 —

 

 

729

 

Gains, losses and other items, net

 

 

300

 

 

2,504

 

Total operating expenses

 

 

90,042

 

 

88,089

 

Income (loss) from operations

 

 

7,120

 

 

(2,056)

 

Other income (expense):

 

 

 

 

 

 

 

Interest expense

 

 

(1,689)

 

 

(1,956)

 

Other, net

 

 

(207)

 

 

59

 

Total other expense

 

 

(1,896)

 

 

(1,897)

 

Income (loss) from continuing operations before income taxes

 

 

5,224

 

 

(3,953)

 

Income taxes (benefit)

 

 

(1,916)

 

 

(2,608)

 

Net earnings (loss) from continuing operations

 

 

7,140

 

 

(1,345)

 

Earnings from discontinued operations, net of tax

 

 

 —

 

 

12,068

 

Net earnings

 

$

7,140

 

$

10,723

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$

0.09

 

$

(0.02)

 

Net earnings from discontinued operations

 

 

 —

 

 

0.15

 

Net earnings

 

$

0.09

 

$

0.14

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$

0.09

 

$

(0.02)

 

Net earnings from discontinued operations

 

 

 —

 

 

0.15

 

Net earnings

 

$

0.09

 

$

0.14

 

 

Some earnings per share amounts may not add due to rounding.

See accompanying notes to condensed consolidated financial statements.

4


 

 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars in thousands, except per share amounts)

 

 

 

For the Six months ended

 

 

 

September 30, 

 

 

    

2016

    

2015

 

 

 

 

 

 

 

 

 

Revenues

 

$

432,068

 

$

404,240

 

Cost of revenue

 

 

242,924

 

 

239,021

 

Gross profit

 

 

189,144

 

 

165,219

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

 

37,681

 

 

39,089

 

Sales and marketing

 

 

75,195

 

 

63,753

 

General and administrative

 

 

60,372

 

 

63,262

 

Impairment of goodwill and other assets

 

 

 —

 

 

729

 

Gains, losses and other items, net

 

 

614

 

 

3,311

 

Total operating expenses

 

 

173,862

 

 

170,144

 

Income (loss) from operations

 

 

15,282

 

 

(4,925)

 

Other income (expense):

 

 

 

 

 

 

 

Interest expense

 

 

(3,501)

 

 

(3,841)

 

Other, net

 

 

100

 

 

363

 

Total other expense

 

 

(3,401)

 

 

(3,478)

 

Income (loss) from continuing operations before income taxes

 

 

11,881

 

 

(8,403)

 

Income taxes (benefit)

 

 

765

 

 

(1,876)

 

Net earnings (loss) from continuing operations

 

 

11,116

 

 

(6,527)

 

Earnings from discontinued operations, net of tax

 

 

 —

 

 

16,211

 

Net earnings

 

$

11,116

 

$

9,684

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$

0.14

 

$

(0.08)

 

Net earnings from discontinued operations

 

 

 —

 

 

0.21

 

Net earnings

 

$

0.14

 

$

0.12

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$

0.14

 

$

(0.08)

 

Net earnings from discontinued operations

 

 

 —

 

 

0.21

 

Net earnings

 

$

0.14

 

$

0.12

 

 

Some earnings per share amounts may not add due to rounding.

See accompanying notes to condensed consolidated financial statements.

 

5


 

 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

For the Three months ended

 

 

 

September 30, 

 

 

    

2016

    

2015

 

 

 

 

 

 

 

 

 

Net earnings

 

$

7,140

 

$

10,723

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

Change in foreign currency translation adjustment

 

 

(65)

 

 

(2,392)

 

Unrealized gain (loss) on interest rate swap

 

 

91

 

 

(81)

 

Other comprehensive income (loss)

 

 

26

 

 

(2,473)

 

Comprehensive income

 

$

7,166

 

$

8,250

 

 

See accompanying notes to condensed consolidated financial statements.

6


 

 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

For the Six months ended

 

 

    

September 30, 

 

 

    

2016

    

2015

 

 

 

 

 

 

 

 

 

Net earnings

 

$

11,116

 

$

9,684

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

Change in foreign currency translation adjustment

 

 

(1,070)

 

 

(1,674)

 

Unrealized gain (loss) on interest rate swap

 

 

96

 

 

(70)

 

Other comprehensive loss

 

 

(974)

 

 

(1,744)

 

Comprehensive income

 

$

10,142

 

$

7,940

 

 

See accompanying notes to condensed consolidated financial statements.

 

 

 

 

7


 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF EQUITY

SIX MONTHS ENDED SEPTEMBER 30, 2016

(Unaudited)

(Dollars in thousands)

 

 

 

    

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Additional

 

 

 

 

other

 

Treasury Stock

 

 

 

 

 

 

Number

 

 

 

 

paid-in

 

Retained

 

comprehensive

 

Number

 

 

 

 

Total 

 

 

    

of shares

    

Amount

    

Capital

    

earnings

    

income

    

of shares

    

Amount

    

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at March 31, 2016

 

130,390,106

 

$

13,039

 

$

1,082,220

 

$

598,501

 

$

8,590

 

(53,030,682)

 

$

(1,003,382)

 

$

698,968

 

Employee stock awards, benefit plans and other issuances

 

718,518

 

 

72

 

 

11,433

 

 

 —

 

 

 —

 

(191,496)

 

 

(4,205)

 

 

7,300

 

Tax impact of stock options and restricted stock

 

 —

 

 

 —

 

 

1,116

 

 

 —

 

 

 —

 

 —

 

 

 —

 

 

1,116

 

Non-cash stock-based compensation

 

27,236

 

 

2

 

 

20,502

 

 

 —

 

 

 —

 

 —

 

 

 —

 

 

20,504

 

Restricted stock units vested

 

767,672

 

 

77

 

 

(77)

 

 

 —

 

 

 —

 

 —

 

 

 —

 

 

 —

 

Acquisition of treasury stock

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

(1,314,840)

 

 

(30,542)

 

 

(30,542)

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(1,070)

 

 —

 

 

 —

 

 

(1,070)

 

Unrealized gain on interest rate swap

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

96

 

 —

 

 

 —

 

 

96

 

Net earnings

 

 —

 

 

 —

 

 

 —

 

 

11,116

 

 

 —

 

 —

 

 

 —

 

 

11,116

 

Balances at September 30, 2016

 

131,903,532

 

$

13,190

 

$

1,115,194

 

$

609,617

 

$

7,616

 

(54,537,018)

 

$

(1,038,129)

 

$

707,488

 

 

See accompanying notes to condensed consolidated financial statements

 

8


 

ACXIOM CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Dollars in thousands)

 

 

    

For the Six months ended September 30, 

 

 

 

2016

    

2015

 

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net earnings

 

$

11,116

 

$

9,684

 

Earnings from discontinued operations, net of tax

 

 

 —

 

 

(16,211)

 

Adjustments to reconcile net earnings to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

41,150

 

 

42,410

 

Loss (gain) on disposal or impairment of assets

 

 

(629)

 

 

161

 

Impairment of goodwill and other assets

 

 

 —

 

 

729

 

Deferred income taxes

 

 

(6,539)

 

 

284

 

Non-cash stock-based compensation expense

 

 

20,504

 

 

15,483

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(1,564)

 

 

(9,281)

 

Other assets

 

 

3,679

 

 

(2,021)

 

Accounts payable and other liabilities

 

 

(21,780)

 

 

(10,336)

 

Deferred revenue

 

 

(9,705)

 

 

2,452

 

Net cash provided by operating activities

 

 

36,232

 

 

33,354

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Capitalized software development costs

 

 

(7,875)

 

 

(6,733)

 

Capital expenditures

 

 

(20,539)

 

 

(23,120)

 

Data acquisition costs

 

 

(267)

 

 

(711)

 

Net cash received from disposition

 

 

16,988

 

 

 —

 

Net cash used in investing activities

 

 

(11,693)

 

 

(30,564)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Payments of debt

 

 

(16,111)

 

 

(71,138)

 

Sale of common stock, net of stock acquired for withholding taxes

 

 

7,300

 

 

4,102

 

Excess tax benefits from stock-based compensation

 

 

1,415

 

 

(552)

 

Acquisition of treasury stock

 

 

(30,542)

 

 

(27,261)

 

Net cash used in financing activities

 

 

(37,938)

 

 

(94,849)

 

Net cash used in continuing operations

 

 

(13,399)

 

 

(92,059)

 

 

 

 

 

 

 

 

 

Cash flows from discontinued operations:

 

 

 

 

 

 

 

Net cash provided by operating activities

 

 

 —

 

 

9,715

 

Net cash provided by investing activities

 

 

 —

 

 

122,831

 

Net cash used in financing activities

 

 

 —

 

 

(206)

 

Net cash provided by discontinued operations

 

 

 —

 

 

132,340

 

Net cash provided by (used in) continuing and discontinued operations

 

 

(13,399)

 

 

40,281

 

Effect of exchange rate changes on cash

 

 

(821)

 

 

(346)

 

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

 

(14,220)

 

 

39,935

 

Cash and cash equivalents at beginning of period

 

 

189,629

 

 

141,010

 

Cash and cash equivalents at end of period

 

$

175,409

 

$

180,945

 

 

 

See accompanying notes to condensed consolidated financial statements.

9


 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

(Unaudited)

(Dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

    

For the Six months ended September 30, 

 

 

 

2016

    

2015

 

Supplemental cash flow information:

 

 

 

 

 

 

 

Cash paid during the period for:

 

 

 

 

 

 

 

Interest

 

$

3,962

 

$

4,337

 

Income taxes, net of refunds

 

 

197

 

 

5,266

 

Prepayment of debt

 

 

 —

 

 

55,000

 

Payments on capital leases and installment payment arrangements

 

 

 —

 

 

63

 

Payments on capital leases and installment payment arrangements of discontinued operations

 

 

 —

 

 

206

 

Other debt payments

 

 

16,111

 

 

16,075

 

 

See accompanying notes to condensed consolidated financial statements.

 

10


 

ACXIOM CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

These condensed consolidated financial statements have been prepared by Acxiom Corporation (“Registrant,” “Acxiom”, we, us or the “Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC” or the “Commission”).  In the opinion of the Registrant’s management, all adjustments necessary for a fair presentation of the results for the periods included have been made, and the disclosures are adequate to make the information presented not misleading.  All such adjustments are of a normal recurring nature.  Certain note information has been omitted because it has not changed significantly from that reflected in Notes 1 through 18 of the Notes to Consolidated Financial Statements filed as part of Item 8 of the Registrant’s annual report on Form 10-K for the fiscal year ended March 31, 2016 (“2016 Annual Report”), as filed with the Commission on May 27, 2016.  This quarterly report and the accompanying condensed consolidated financial statements should be read in connection with the 2016 Annual Report.  The financial information contained in this quarterly report is not necessarily indicative of the results to be expected for any other period or for the full fiscal year ending March 31, 2017.

 

Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).  Actual results could differ from those estimates.  Certain of the accounting policies used in the preparation of these condensed consolidated financial statements are complex and require management to make judgments and/or significant estimates regarding amounts reported or disclosed in these financial statements.  Additionally, the application of certain of these accounting policies is governed by complex accounting principles and their interpretation.  A discussion of the Company’s significant accounting principles and their application is included in Note 1 of the Notes to Consolidated Financial Statements and in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the Company’s 2016 Annual Report.

 

Unless otherwise indicated, information in these notes to the condensed consolidated financial statements relates to continuing operations.

 

Accounting Pronouncements Adopted During the Current Year

 

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows: Clarification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”).  The new standard eliminates the diversity in practice related to the classification of certain cash receipts and payments in the statement of cash flows by adding or clarifying guidance on eight specific cash flow issues, including payments for debt prepayments or extinguishments. ASU 2016-15 is effective for annual and interim reporting periods beginning after December 15, 2017 (fiscal 2019 for the Company) and early adoption is permitted. ASU 2016-15 provides for retrospective application for all periods presented. We early adopted the new standard during the current fiscal quarter ended September 30, 2016.  Early adoption did not result in any changes to our existing accounting policies, presentation of items in our condensed consolidated statements of cash flows, or any changes resulting from the retrospective application to all periods reported.

 

Recent Accounting Pronouncements Not Yet Adopted

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting as part of its simplification initiative. The objective of the simplification initiative is to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced while maintaining the usefulness of the information provided to users of financial statements. The areas for simplification in ASU 2016-09 involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for

11


 

annual periods beginning after December 15, 2016 (fiscal 2018 for the Company), including interim periods within those fiscal years.  Earlier adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial condition, results of operations and cash flows.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as a comprehensive new standard that amends various aspects of existing guidance for leases and requires additional disclosures about leasing arrangements. The new standard will require lessees to recognize lease assets and lease liabilities for those leases classified as operating leases under previous guidance, ASC 840, Leases. ASU 2016-02 creates a new Topic, ASC 842, Leases. This new Topic retains a distinction between finance leases and operating leases. The classification criteria for distinguishing between finance leases and operating leases are substantially similar to the classification criteria for distinguishing between capital leases and operating leases in the previous leases guidance. ASU 2016-02 is effective for annual periods beginning after December 15, 2018 (fiscal 2020 for the Company), including interim periods within those fiscal years. Earlier adoption is permitted. In the financial statements in which the ASU is first applied, leases shall be measured and recognized at the beginning of the earliest comparative period presented with an adjustment to equity. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial condition, results of operations and cash flows.

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers: Topic 606, to supersede nearly all existing revenue recognition guidance under U.S. GAAP, as well as some cost guidance and guidance on certain gains and losses. The FASB also issued ASU 2016-08, Revenue from Contracts with Customers – Principal versus Agent Considerations, and ASU 2016-10, Revenue from Contracts with Customers – Identifying Performance Obligations and Licensing.  The core principle of the new guidance is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The guidance defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation, among other areas. The effective date for the update has been deferred until fiscal 2019 for the Company, with early application allowed for fiscal 2018.  Adoption of the update may be applied using either of two methods: (i) retrospective application to each prior reporting period presented with the option to elect certain practical expedients; or (ii) retrospective application with the cumulative effect recognized at the date of initial application and providing certain additional disclosures. The Company has completed its assessment phase of the new standard and commenced the design phase. The Company cannot currently estimate the financial statement impact of adoption.

 

The Company does not anticipate that the adoption of any other recent accounting pronouncements will have a material impact on the Company's consolidated financial position, results of operations, or cash flows.

 

 

12


 

2.EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

 

Earnings (Loss) Per Share

 

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):

 

 

    

For the quarter ended

 

For the six months ended

 

 

 

September 30, 

 

September 30, 

 

 

 

2016

    

2015

    

2016

    

2015

    

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations

 

$

7,140

 

$

(1,345)

 

$

11,116

 

$

(6,527)

 

Net earnings from discontinued operations, net of tax

 

 

 —

 

 

12,068

 

 

 —

 

 

16,211

 

Net earnings

 

$

7,140

 

$

10,723

 

$

11,116

 

$

9,684

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

 

77,446

 

 

77,960

 

 

77,459

 

 

77,939

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.09

 

$

(0.02)

 

$

0.14

 

$

(0.08)

 

Discontinued operations

 

 

 —

 

 

0.15

 

 

 —

 

 

0.21

 

Net earnings

 

$

0.09

 

$

0.14

 

$

0.14

 

$

0.12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

 

77,446

 

 

77,960

 

 

77,459

 

 

77,939

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

 

1,831

 

 

 —

 

 

1,858

 

 

 —

 

Diluted weighted-average shares outstanding

 

 

79,277

 

 

77,960

 

 

79,317

 

 

77,939

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.09

 

$

(0.02)

 

$

0.14

 

$

(0.08)

 

Discontinued operations

 

 

 —

 

 

0.15

 

 

 —

 

 

0.21

 

Net earnings

 

$

0.09

 

$

0.14

 

$

0.14

 

$

0.12

 

 

Some earnings per share amounts may not add due to rounding.

 

Due to the net loss from continuing operations incurred by the Company during the quarter and six months ended September 30, 2015, the dilutive effect of options, warrants and restricted stock units covering 1.4 million shares of common stock was excluded in each period from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.

 

Additional options and warrants to purchase shares of common stock and restricted stock units, including performance-based restricted stock units not meeting performance criteria, that were outstanding during the periods presented but were not included in the computation of diluted earnings per share because the effect was anti-dilutive are shown below (in thousands, except share price amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

For the quarter ended

 

For the six months ended

 

 

 

September 30, 

 

September 30, 

 

 

 

2016

    

2015

 

2016

    

2015

 

Number of shares outstanding under options, warrants and restricted stock units

 

 

39

 

 

1,946

 

 

263

 

 

1,915

 

Range of exercise prices for options

 

$

20.27 -  $32.85

 

$

2.58 -  $62.06

 

$

20.27 -  $32.85

 

$

2.58 -  $62.06

 

 

Stockholders’ Equity

 

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded, most recently on July 28, 2016.  Under the modified common stock

13


 

repurchase program, the Company may purchase up to $400.0 million of its common stock through the period ending June 30, 2018. During the six months ended September 30, 2016, the Company repurchased 1.3 million shares of its common stock for $30.5 million.  Through September 30, 2016, the Company had repurchased 16.8 million shares of its stock for $285.7 million, leaving remaining capacity of $114.3 million under the stock repurchase program.

 

Accumulated Other Comprehensive Income

 

The following table presents the accumulated balances for each component of other comprehensive income (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

    

September 30, 

    

March 31, 

 

 

 

2016

 

2016

 

Foreign currency translation

 

$

7,634

 

$

8,705

 

Unrealized loss on interest rate swap

 

 

(18)

 

 

(115)

 

 

 

$

7,616

 

$

8,590

 

 

 

 

 

 

 

 

 

 

 

 

 

3.SHARE-BASED COMPENSATION:

 

Share-based Compensation Plans

 

The Company has stock option and equity compensation plans for which a total of 28.9 million shares of the Company’s common stock have been reserved for issuance since the inception of the plans.  These plans provide that the exercise prices of qualified options will be at or above the fair market value of the common stock at the time of the grant.  Board policy requires that nonqualified options also be priced at or above the fair market value of the common stock at the time of grant.  At September 30, 2016, there were a total of 2.2 million shares available for future grants under the plans.

 

Stock Option Activity

Stock option activity for the six-month period ended September 30, 2016 was:

 

    

 

    

 

 

    

Weighted-‑average

    

 

 

 

 

 

 

 

Weighted-average

 

remaining

 

Aggregate

 

 

 

Number of

 

exercise price

 

contractual term

 

Intrinsic value

 

 

 

shares

 

per share

 

(in years)

 

(in thousands)

 

Outstanding at March 31, 2016

 

3,604,102

 

$

14.52

 

 

 

 

 

 

Exercised

 

(498,180)

 

$

13.82

 

 

 

$

4,848

 

Forfeited or cancelled

 

(47,833)

 

$

16.24

 

 

 

 

 

 

Outstanding at September 30, 2016

 

3,058,089

 

$

14.60

 

5.4

 

$

36,961

 

Exercisable at September 30, 2016

 

2,353,864

 

$

14.49

 

4.6

 

$

28,685

 

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between Acxiom’s closing stock price on the last trading day of the quarter and the exercise price for each in-the-money option) that would have been realized by the option holders had option holders exercised their options on September 30, 2016.  This amount changes based upon changes in the fair market value of Acxiom’s common stock.

 

14


 

A summary of stock options outstanding and exercisable as of September 30, 2016 is presented below:

 

 

 

 

 

 

 

Options outstanding

 

Options exercisable

 

Range of

 

 

 

Weighted-average

 

Weighted-average

 

 

 

Weighted-average

 

exercise price

 

Options

 

 remaining

 

exercise price

 

Options

 

exercise price

 

per share

    

outstanding

    

contractual life

 

per share

    

exercisable

    

per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.85

-

$

9.99

 

581,070

 

6.6

years

 

$

1.86

 

403,973

 

$

1.80

 

$

10.00

-

$

19.99

 

1,611,798

 

5.3

years

 

$

15.22

 

1,294,109

 

$

14.59

 

$

20.00

-

$

24.99

 

845,669

 

4.6

years

 

$

21.77

 

646,008

 

$

21.95

 

$

25.00

-

$

32.85

 

19,552

 

7.1

years

 

$

32.85

 

9,774

 

$

32.85

 

 

 

 

 

 

 

3,058,089

 

5.4

years

 

$

14.60

 

2,353,864

 

$

14.49

 

 

Total expense related to stock options for the six months ended September 30, 2016 and 2015 was approximately $3.5 million and $5.9 million, respectively.  Future expense for these options is expected to be approximately $6.1 million over the next four years.

 

Performance Stock Option Unit Activity

On June 29, 2016, the Company granted 633,604 performance-based stock option units with a value at the date of grant of $4.9 million, determined using a Monte Carlo simulation model.  All of the units granted in the current period vest and become exercisable in three equal tranches, each being subject to attainment of performance criteria and a subsequent service period established by the compensation committee of the board of directors (“Comp Committee”).  Each of the three tranches may vest in a number of stock options, from zero to 300% of the initial award, each having an exercise price of $21.40, based on the attainment of certain revenue growth and operating margin targets for the years ending March 31, 2017, 2018, and 2019 respectively. Each tranche is subject to a service period following the respective performance periods, such that each tranche will cliff vest in two separate 50% increments over two years beginning with the Comp Committee meeting that immediately follows the end of the respective performance period.     

 

Performance stock option unit activity for the six-month period ended September 30, 2016 was:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted-average

    

 

 

 

 

 

 

 

 

Weighted-average

 

remaining

 

 

Aggregate

 

 

 

Number

 

 

exercise price

 

contractual term

 

 

intrinsic value

 

 

 

of shares

 

 

per share

 

(in years)

 

 

(in thousands)

 

Outstanding at March 31, 2016

 

 —

 

$

 —

 

 

 

 

 

 

Granted

 

633,604

 

$

21.40

 

 

 

 

 

 

Outstanding at September 30, 2016

 

633,604

 

$

21.40

 

1.6

 

$